Abstract
MICs and MBCs of four new macrolides (azithromycin, clarithromycin, dirithromycin and roxithromycin) and two older macrolides (erythromycin and josamycin) forBordetella pertussis andBordetella parapertussis were determined. The activity of the new macrolides was as good as that of erythromycin, while josamycin was slightly less active.Bordetella parapertussis was more resistant thanBordetella pertussis.
Similar content being viewed by others
References
Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J., Fernandes, P. B. Comparative in vitro activities of new 14-, 15-, and 16-membered macroblides. Antimicrobial Agents and Chemotherapy 1988, 32: 1710–1719.
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A. NCCLS, Villanova, PA, 1985.
Hoppe, J. E., Haug, A., Botzenhart, K. Susceptibility ofBordetella pertussis andBordetella parapertussis to twenty-four antibiotics. Chemotherapy 1987, 33: 250–254.
Kurzynski, T. A., Boehm, D. M., Rott-Petri, J. A., Schell, R. F., Allison, P. E. Antimicrobial susceptibilities ofBordetella species isolated in a multicenter pertussis surveillance project. Antimicrobial Agents and Chemotherapy 1988, 32: 137–140.
Hoppe, J. E., Haug, A. Antimicrobial susceptibility ofBordetella pertussis. Infection 1988, 16: 126–130.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoppe, J.E., Eichhorn, A. Activity of new macrolides againstBordetella pertussis andBordetella parapertussis . Eur. J. Clin. Microbiol. Infect. Dis. 8, 653–654 (1989). https://doi.org/10.1007/BF01968151
Issue Date:
DOI: https://doi.org/10.1007/BF01968151